CATALINA-2: A Phase 2 Study Evaluating the Efficacy and Safety of TORL-1-23 in Women with Advanced Platinum-Resistant Epithelial Ovarian Cancer (Including Primary Peritoneal and Fallopian Tube Cancers) Expressing Claudin 6.

Project: Research

Project Details

Project Description



StatusActive
Effective start/end date11/04/25 → 10/04/30

Clinical Trial Phase

  • Phase II